Navigation Links
ThromboGenics Completes Patient Enrolment for Phase II Trial of Microplasmin for the Treatment of Diabetic Macular Edema (MIVI II DME)
Date:3/6/2009

et="_new">http://www.thrombogenics.com.

Important information about forward-looking statements

Certain statements in this press release may be considered "forward-looking". Such forward-looking statements are based on current expectations, and, accordingly, entail and are influenced by various risks and uncertainties. The Company therefore cannot provide any assurance that such forward-looking statements will materialize and does not assume an obligation to update or revise any forward-looking statement, whether as a result of new information, future events or any other reason. Additional information concerning risks and uncertainties affecting the business and other factors that could cause actual results to differ materially from any forward-looking statement is contained in the Company's Annual Report.

    For further information please contact:

    ThromboGenics
    Dr. Steve Pakola, CMO
    Tel: +1-(212)-201-0920
    steve.pakola@thrombogenics.com

    Dr. Patrik De Haes, CEO
    Tel: +32-16-75-13-10
    patrik.dehaes@thrombogenics.com

    Citigate Dewe Rogerson
    Amber Bielecka/ David Dible/ Nina Enegren
    Tel: +44-(0)207-638-95-71
    amber.bielecka@citigatedr.co.uk



'/>"/>
SOURCE ThromboGenics NV
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ThromboGenics and BioInvent Receive Technology Transfer Success Fee From Roche for the Novel Anti-Cancer Antibody, TB-403 (Anti-PIGF)
2. ThromboGenics Begins Phase III Program With Microplasmin for the Non-surgical Treatment of Back of the Eye Disease
3. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
4. ThromboGenics Completes Patient Enrolment in the Phase IIb Trial of Microplasmin in Vitrectomy (MIVI III)
5. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
6. Oramed Pharmaceuticals Completes Proof of Concept Study of Insulin Suppository
7. Alseres Pharmaceuticals Completes Enrollment in First Stage of the Altropane(R) POET-2 Phase III Program
8. PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
9. Duska Therapeutics Completes Corporate Name Change to Cordex Pharma
10. Trius Completes Enrollment in Phase 2 Clinical Trial Evaluating Torezolid (TR-701) in Patients With Complicated Skin and Skin Structure Infections
11. Algeta Completes Comprehensive Phase II Clinical Program With Alpharadin for Treating Bone Metastases in Patients With Advanced Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... new market research report is available ... Therapeutics to 2020 - Broadened Diagnostic ... Drive Market Growth despite Patent Expirations ... ADHD Therapeutics to 2020 ...
(Date:8/28/2014)... Ohio , Aug. 28, 2014  A ... competition in generics are adding pressure to pharmaceutical, ... resources. Company resources continue to shrink and approval ... This has led companies to look for additional ... commercialization and for keeping approved products on the ...
(Date:8/28/2014)... 28. August 2014 Sequent ... der Patientenrekrutierung für eine IDE-Pivot-Studie („IDE" ... Beurteilung der Sicherheit und Wirksamkeit des ... („WEB") bekanntgegeben. Adam Arthur, MD, Dozent an ... Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt der WEB-IT-Studie, ...
Breaking Medicine Technology:ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 2ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 3ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 4ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 5ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 6ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 7ADHD Therapeutics to 2020 - Broadened Diagnostic Criteria and Growing Adult Prevalence to Drive Market Growth despite Patent Expirations 84 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 24 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 34 Key Factors to Consider When Choosing an Effective Regulatory Outsourcing Partner 4Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3
... European Association for the Study of ... Diabetes Annual Meeting, ... Annual Meeting of the European Association for the Study,of Diabetes demonstrate ... cardiovascular disease in patients with type 2,diabetes. ACTOS is an oral ...
... Therapy, ALEXANDRIA, La., Sept. 18 Life ... NJ, an emerging provider of,groundbreaking medical devices for ... ThermoSuit(R) System has been granted European CE,Mark (Conformite ... indicated, e.g., to induce hypothermia in patients to,preserve ...
Cached Medicine Technology:ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 2ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes 3Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System 2
(Date:8/28/2014)... Dallas, TX (PRWEB) August 29, 2014 ... and in-depth study on the current state of the ... provides a basic overview of the industry, including definitions, ... Chinese domestic market analysis are provided with a focus ... market. A comparison between the international and Chinese situation ...
(Date:8/28/2014)... 29, 2014 Top10BestSEOHosting.com has recently ... that FatCow, Hostgator and Bluehost are the best ... ) has been working in the hosting industry ... is connected to multiple GB connections to ensure ... disruptions to customers’ websites. The great thing is ...
(Date:8/28/2014)... August 28, 2014 Millennium Treatment ... throughout September. This month will be a celebration ... mental health services. Along with other treatment facilities ... helping to spread the word about this national ... honoring the work of treatment and recovery professionals, ...
(Date:8/28/2014)... American adults who are beginning to research providers ... have a simpler way to connect with companies using ... some of the best life insurance rates available are ... promoted plans that included price data revealed to adults ... The term, guaranteed and modified plans that might be ...
(Date:8/28/2014)... Chicago (PRWEB) August 28, 2014 ABC ... on the 49th MDA Show of Strength Telethon airing ... the country to help raise funds and awareness to ... adults affected by muscle disease. , Viewers tuning into ... will enjoy heart-felt appeals and introductions from some of ...
Breaking Medicine News(10 mins):Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 2Health News:Global Oscilloscope Industry (North America, Europe, Asia, and ROW) Forecast Report 2020 Now Available at ReportsnReports.com 3Health News:Best Suppliers of Affordable Hosting Products Introduced by Top10BestSEOHosting.com 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Best Life Insurance Rates for 2014 Now Promoted at Insurer Website 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 2Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 3Health News:ABC Stars Unite to Fight Back Against Muscle Disease During MDA Show of Strength Telethon 4
... Annual Spring Meeting of the European Society of Cardiology ... in cooperation with the Irish Nurses Cardiovascular Association (INCA), ... Ireland, on 24-25 April. , The meeting - ... for nurses and allied health professionals - will show ...
... Essence Orthopaedics, Inc., a medical device company focused ... extremities, today announced that it has received 510(k) ... (FDA) for SECURUS(TM), a novel knotless suture anchor ... provides increased flexibility, simplicity, and ease for surgeons ...
... 8 Manufacturers, sales of OTC drugs grew by ... in 2008, according to the latest research in ... from worldwide consulting and research firm Kline & Company.Private-label ... period, within which antacids and allergy medicines posted the ...
... Many diseases derive from problems with cellular respiration, the ... at the Swedish medical university Karolinska Institutet have now ... mitochondrion popularly called the cell,s power station ... Every time we take a breath, our blood transports ...
... less-expensive medical care , , WEDNESDAY, April 8 (HealthDay News) -- ... to Bangkok for his first colonoscopy. , There ... of nurses, who verified his identity 15 times before the ... motive: He is founder and president of Companion Global Healthcare, ...
... have access to most comprehensive Spanish-language Web site in ... Caremark (NYSE: CVS ) today announced the ... Web site makes it easier for Spanish-speaking CVS Caremark ... providing them with online information and access to help ...
Cached Medicine News:Health News:Telemonitoring changes the working practice of cardiac nurses 2Health News:Telemonitoring changes the working practice of cardiac nurses 3Health News:Telemonitoring changes the working practice of cardiac nurses 4Health News:Telemonitoring changes the working practice of cardiac nurses 5Health News:Telemonitoring changes the working practice of cardiac nurses 6Health News:Core Essence Receives FDA Approval for SECURUS(TM), an Innovative Knotless Suture Anchor System 2Health News:Core Essence Receives FDA Approval for SECURUS(TM), an Innovative Knotless Suture Anchor System 3Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 2Health News:Private-label OTC Drugs Post Solid Gains in 2008, According to Kline 3Health News:Key protein in cellular respiration discovered 2Health News:Traveling for Treatment 2Health News:Traveling for Treatment 3Health News:Traveling for Treatment 4Health News:CVS Caremark Launches Spanish Version of Caremark.com 2Health News:CVS Caremark Launches Spanish Version of Caremark.com 3
... System Produces Type I Water Directly from Tap, ... for scientists who need 5 to 15 L ... have easy access to acceptable quality pretreated water. ... L/min of ultrapure (Type I) water on demand, ...
... weighing mechanism for speed, stability and ... analog display modes, multiple units of ... functions, auto print, and GLP/GMP/ISO output ... built-in clock. Touch-key calibration with external ...
... for speed, stability and durability. Back-lighted ... modes, multiple units of measure, piece ... print, and GLP/GMP/ISO output including date ... Built-in, motor-driven internal calibration mass ...
... - Battery Powered (6 size AA required). ... (g, ct, oz, ozt, GN, dwt, mom, ... and Percent Measure functions, Auto Print. Optional ... AC adapter may be ordered for AC ...
Medicine Products: